相关实验视频
Updated: Jan 13, 2026

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.5K
多因素慢性病和的能力-工作负载平衡.
Paola Romagnani1,2, Juliana C N Chan3, Hans-Joachim Anders4
1Nephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Nature reviews. Nephrology
|January 6, 2026
概括
慢性病 (CKD) 通常是由多个因素引起的,而不是单一的原因. 了解这种多因素性质是改善病诊断和治疗的关键.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
背景情况:
- 慢性病 (CKD) 影响全球大约10%的人口.
- 传统上,CKD以单一的假定原因进行分类,这是脏病学培训的核心概念.
- 识别单一的病因驱动因素是诊断病的基石.
研究的目的:
- 挑战传统的CKD单一原因模型.
- 提出和探索CKD作为多因素条件的概念.
- 突出多因素视角对CKD诊断和管理的影响.
主要方法:
- 对CKD病因学现有数据的审查和概念分析.
- 探索对脏侮辱和风险因素的终身视角.
- 来自多因素模型的临床影响的讨论.
主要成果:
- 常见的CKD通常是由于累积或同时暴露于多种侮辱和风险因素造成的.
- 单一原因模型可能无法准确地反映许多患者中CKD发展的复杂现实.
- 多因素观点更好地与临床观察和患者的结果保持一致.
结论:
- 慢性瘤通常是多因素的,由连续或多次同时受到的侮辱引起.
- 采用CKD的多因素概念对诊断方法,命名和治疗策略有重大影响.
- 基于风险因素的多因素方法为优先考虑风险因素控制以保护脏健康提供了强有力的理由.
相关概念视频
Chronic Kidney Disease I: Introduction
556
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
556
Chronic Kidney Disease III: Interprofessional Care
333
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
Factors Affecting Renal Clearance: Renal Impairment
415
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
415
Chronic Kidney Disease IV: Nursing Management
312
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
312
Chronic Kidney Disease II: Clinical Manifestations
543
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
543
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
205
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
205

